Skip to content

The Journal for ImmunoTherapy of Cancer

Just another bmjjournals-chicken.bmj.com Managed WordPress Site Sites site

T-cell tolerant fraction as a predictor of immune-related adverse events

$Visual abstract of T-cell tolerant fraction as a predictor of immune-related adverse events$

Post navigation

Previous post

TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy

Next post

Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis

Search

Recent Posts

Robots

Recent Comments

No comments to show.

Archives

September 2022

Categories

Uncategorized

The Journal for ImmunoTherapy of Cancer

Proudly powered by WordPress.